A major multi-country study has found that WHO-recommended first-line antibiotics for neonatal sepsis are likely to be effective in only one quarter of infections in low- and middle-income countries ...
Sepsis leads to life-threatening organ failure due to dysregulated host responses to infection and presents uniquely across age groups. Neonatal sepsis, affecting infants in their first 28 days, ...
Striking at the heart of antimicrobial resistance, the international NeoSep 1 trial to evaluate life-saving antibiotic combinations for newborns with sepsis has expanded to India, with the first baby ...
A major multi-country study has found that WHO-recommended first-line antibiotics for neonatal sepsis are likely to be effective in only one-quarter of infections in low- and middle-income countries ...
Health and Me on MSN
Sepsis: India joins global trial to screen newborns for deadly drug-resistant infections
The NeoSep1 trial is expected to enroll 3,000 newborns across Asia and Africa by the end of 2028. Along with India, newborns have already been enrolled in Ghana, Kenya, and South Africa. Hospitals in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results